John P. Longenecker Ph.D., President and CEO at AILERON THERAPEUTICS INC (ALRN), bought 10,000 shares at $2.45 ($25K) on 2018-08-10, disclosed to the SEC on 2018-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCRX | SELL | 2019-12-04 | $60K | — | Filing → |
| PCRX | BUY | 2016-01-14 | $20K | — | Filing → |
| PCRX | SELL | 2015-03-16 | $286K | — | Filing → |